By Maureen Corrigan — 2017
A Really Good Day is Waldman’s first-person account of her month-long adventure microdosing LSD.
Read on www.npr.org
CLEAR ALL
LSD Psychotherapy is a valuable source of information for those who are involved with LSD in any way, as parents, teachers, researchers, legistlators or students of the human psyche.
1
When a small vial arrives in her mailbox from "Lewis Carroll," Ayelet Waldman is ready to try anything. Her depression has become intolerable, severe and unmanageable; medication has failed to make a difference.
Some say LSD produces hallucinations and lowers inhibitions. Others believe it makes people more capable, efficient and creative. In Silicon Valley, many even say LSD can be a tool for self-improvement.
Ayelet Waldman is the author of several novels, and A Really Good Day, a book that documents a month microdosing LSD as a radical solution to a life of suicidal depression. With humor and candor she introduces us to this story and describes the outcome.
Learn how to microdose acid (LSD) or magic mushrooms in this educational whiteboard video. Produced by Mark from After Skool and Brandon from OnePercentBetter.
Microdosing is when you take a tiny amount of psychedelic drugs - LSD or magic mushrooms usually - as part of your ordinary day. The drugs are illegal, and there is no medical evidence to say what the benefits or harms of it may be.
2
With the F.D.A. agreeing to new trials to test MDMA (better known as Ecstasy) as a treatment for PTSD—which, if approved, could be available as a drug by 2021—Acid Test is leading the charge in an evolving conversation about psychedelic drugs.
A pioneering book that explores the unknown landscape of human consciousness induced by LSD and other psychedelics • Shows the relationship between shamanism, near death experiences, and other mystical and altered states with those induced by psychedelics • Lays the conceptual foundation for...
The sensationalism surrounding the widespread use of LSD in the late 60s and the subsequent legislative overkill virtually ended psychotherapeutic LSD research.
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.